Innealta Capital’s Chemours CC Stock Holding History

Innealta Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54	Closed	-$1.22K	–	406
2024 Q2	$1.22K	Buy	+54	New	+$1.41K	﹤0.01%	1261

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Innealta Capital's CC Position: Q3 2024 in Review

Innealta Capital sold out of Chemours (CC) in Q3 2024, closing a stake of 54 shares — an estimated $1.22K sold.

Innealta Capital first reported a position in CC in Q2 2024 and held it in 1 quarter. The position peaked at $1.22K in Q2 2024. 422 funds tracked by Wall St. Rank hold CC as of Q3 2024.

Innealta Capital reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 54 Chemours shares in Q3 2024, an estimated $1.22K.
Innealta Capital first reported a position in Chemours in Q2 2024 and held it in 1 quarter.
Innealta Capital's Chemours position peaked at $1.22K in Q2 2024.
422 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.